ストックスクリーナーアプリを入手
22.01
5.01%
1.05
Acadia Pharmaceuticals Inc (ACAD) 最新ニュース
This General Motors Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday - Benzinga
Acadia Pharmaceuticals upgraded on improve risk-reward profile following pullback - Proactive financial news
Acadia Pharmaceuticals (ACAD) Upgraded to Buy by BofA - GuruFocus
Acadia Pharma upgraded at BofA following stock pullback - MSN
Acadia Pharmaceuticals upgraded to Buy at BofA following 25% pullback - TipRanks
ACAD: B of A Securities Upgrades ACADIA Pharmaceuticals Rating t - GuruFocus
ACADIA Pharmaceuticals (NASDAQ:ACAD) Raised to "Buy" at Bank of America - MarketBeat
BofA upgrades Acadia Pharmaceuticals stock rating on valuation By Investing.com - Investing.com Canada
RBC Capital Maintains ACADIA Pharmaceuticals(ACAD.US) With Buy Rating, Maintains Target Price $30 - Moomoo
Hudson Bay Capital Management LP Sells 119,700 Shares of ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
Market Recap: How does ACADIA Pharmaceuticals Inc compare to its peersBreakout Watch & Intraday High Probability Setup Alerts - baoquankhu1.vn
Hedge Fund Moves: How does ACADIA Pharmaceuticals Inc compare to its peersProfit Target & Long-Term Safe Investment Plans - baoquankhu1.vn
Aug Outlook: Does ACADIA Pharmaceuticals Inc offer margin of safety2026 Analyst Calls & Fast Entry and Exit Trade Plans - baoquankhu1.vn
Acadia (NASDAQ: ACAD) director receives new option and RSU awards - Stock Titan
ACADIA (NASDAQ: ACAD) director Jonathan Poole submits initial Form 3 insider report - Stock Titan
ACAD Stock Down 10% Following Phase III Hyperphagia Study Failure - MSN
Mizuho upgrades ACADIA Pharmaceuticals (ACAD) - MSN
Oppenheimer maintains a balanced outlook on ACADIA Pharmaceuticals Inc. (ACAD) for 2026 - MSN
Wolfe Research notes conviction-driven opportunities in ACADIA Pharmaceuticals Inc.’s (ACAD) therapeutic domains - MSN
ACADIA Pharmaceuticals invites engagement at major pediatric event - Traders Union
ACADIA Pharmaceuticals Inc. (ACAD) Latest Stock News & Headlines - Yahoo Finance
ACADIA Pharmaceuticals Maps Key CNS Readouts: Remlifanserin ADP Data Due Aug–Oct, ACP-211 Next Year - Yahoo Finance
ACADIA Pharmaceuticals at Stifel CNS Forum: Strategic Insights Unveiled - Investing.com India
ACADIA Pharmaceuticals at Stifel CNS Forum: Strategic Insights Unveiled By Investing.com - Investing.com Canada
Algert Global LLC Has $8.54 Million Stake in ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
(ACAD) Movement as an Input in Quant Signal Sets - Stock Traders Daily
ACADIA Pharmaceuticals (ACAD) Is Down 5.3% After EMA Rejects Trofinetide In Rett ReviewWhat's Changed - simplywall.st
Acadia Pharmaceuticals annual revenue surpasses 1 billion dollars at Nasdaq bell ceremony - Traders Union
Acadia Pharmaceuticals Rings the Opening Bell - Nasdaq
Acadia Pharmaceuticals Rings the Nasdaq Stock Market Opening Bell - Nasdaq
Fred Alger Management LLC Sells 820,421 Shares of ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
Assessing ACADIA Pharmaceuticals (ACAD) Valuation After Recent Share Price Weakness - Yahoo Finance
Braidwell LP Makes New $50.76 Million Investment in ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
ACADIA Pharmaceuticals confirms role at Stifel 2026 Virtual CNS Forum - Traders Union
Has ACADIA Pharmaceuticals (ACAD) Pullback Opened A New Opportunity For Investors? - simplywall.st
Acadia Pharmaceuticals appoints Jonathan M. Poole to board of directors By Investing.com - Investing.com Nigeria
ACADIA Pharmaceuticals Inc. $ACAD Shares Sold by First Trust Advisors LP - MarketBeat
ACADIA Pharmaceuticals unveils new Rett Syndrome research at Baltimore genetics meeting - Traders Union
Acadia Pharmaceuticals to Participate in the Stifel 2026 Virtual CNS Forum - The AI Journal
Acadia Pharmaceuticals at The Citizens Life Sciences Conference: Strategic Growth and Innovations - Investing.com India
ACADIA Pharmaceuticals Showcases $1B+ Net Sales, $800M Cash, and Key Alzheimer’s Readout Ahead - MarketBeat
Equity grants for ACADIA (ACAD) principal accounting officer - Stock Titan
Acadia (ACAD) CFO receives new stock options and RSU awards - Stock Titan
ACADIA (NASDAQ: ACAD) awards options and RSUs to Chief Commercial Officer - Stock Titan
Acadia (NASDAQ: ACAD) EVP awarded large stock option and RSU grants - Stock Titan
Acadia Pharmaceuticals (ACAD) grants CEO large options and RSUs - Stock Titan
ACADIA Pharmaceuticals to exhibit at ACMG event in Baltimore - Traders Union
ACADIA Pharmaceuticals (ACAD) Stock Analysis Report | Ratings, Financials & Performance - Benzinga Japan
ACAD plans re-examination after CHMP rejects Rett syndrome drug in EU (revised) - MSN
Neo Ivy Capital Management Buys Shares of 62,568 ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
ACADIA Pharmaceuticals (ACAD) Valuation After CHMP Setback On Trofinetide For Rett Syndrome - Sahm
Acadia Pharmaceuticals Appoints Jonathan Poole to Board, Audit Committee - The Globe and Mail
Acadia Pharmaceuticals appoints Jonathan M. Poole to board of directors - Investing.com India
1.82%
大文字化:
|
ボリューム (24 時間):